Literature DB >> 20740574

Low Ki-67 proliferation index is an indicator of poor prognosis in gastric cancer.

Hee Eun Lee1, Min A Kim, Byung Lan Lee, Woo Ho Kim.   

Abstract

BACKGROUND AND OBJECTIVES: We designed this study to assess the biologic significance of Ki-67 proliferation index (PI) in gastric cancer.
METHODS: Gastric cancer tissue from 245 patients were immunostained for Ki-67. Ki-67 PI was defined as the percentage of tumor cells positive for Ki-67. In addition, we have previously evaluated the expressions of nine epithelial mesenchymal transition (EMT)-related proteins. The relationship between Ki-67 PI and clinicopathologic parameters, patient survival, and EMT data were sought.
RESULTS: Low Ki-67 PI was correlated with poorly differentiated histology (P = 0.034), an advanced T stage (P < 0.001), and lymph node metastasis (P = 0.011). Also, the low PI group was found to have a significantly worse prognosis than the high PI group (P = 0.003, log-rank test). Multivariate analysis revealed that Ki-67 PI remained as an independent prognostic factor (hazard ratio (95% CI) = 0.670 (0.450-0.999)). Furthermore, greater expressional changes of EMT-related proteins were found to be significantly associated with low Ki-67 PI (P = 0.025).
CONCLUSIONS: These findings suggest that Ki-67 PI is an effective tool for predicting survival in gastric cancer. In addition, we found that an invasive property presented as EMT-related protein expressional changes was inversely correlated with a proliferative activity in gastric cancer. 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20740574     DOI: 10.1002/jso.21583

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  15 in total

1.  Combined evaluation of the expression of NUCKS and Ki-67 proteins as independent prognostic factors for patients with gastric adenocarcinoma.

Authors:  Ming Yang; Xiaoxia Wang; Qi Zhao; Tianbo Liu; Guodong Yao; Wenhao Chen; Zhiwei Li; Xiaoyi Huang; Yanqiao Zhang
Journal:  Tumour Biol       Date:  2014-05-02

2.  Expression and clinical significance of glucose transporter-1 in pancreatic cancer.

Authors:  Kai Lu; Jian Yang; DE-Chun Li; Song-Bing He; Dong-Ming Zhu; Li-Feng Zhang; X U Zhang; Xiao-Chen Chen; Bing Zhang; Jian Zhou
Journal:  Oncol Lett       Date:  2016-05-16       Impact factor: 2.967

3.  Clinicopathological and prognostic significance of Ki-67, caspase-3 and p53 expression in gastric carcinomas.

Authors:  Li-Jun Xiao; Shuang Zhao; En-Hong Zhao; Xin Zheng; Wen-Feng Gou; Yasuo Takano; Hua-Chuan Zheng
Journal:  Oncol Lett       Date:  2013-08-19       Impact factor: 2.967

4.  The role of the obestatin/GPR39 system in human gastric adenocarcinomas.

Authors:  Begoña O Alén; Saúl Leal-López; María Otero Alén; Patricia Viaño; Victoria García-Castro; Carlos S Mosteiro; Andrés Beiras; Felipe F Casanueva; Rosalía Gallego; Tomás García-Caballero; Jesús P Camiña; Yolanda Pazos
Journal:  Oncotarget       Date:  2016-02-02

5.  Long noncoding RNA OR3A4 promotes metastasis and tumorigenicity in gastric cancer.

Authors:  Xiaobo Guo; Ziguo Yang; Qiaoming Zhi; Dan Wang; Lei Guo; Guimei Li; Ruizhen Miao; Yulong Shi; Yuting Kuang
Journal:  Oncotarget       Date:  2016-05-24

Review 6.  Clinicopathologic significance and prognostic value of Ki-67 expression in patients with gastric cancer: a meta-analysis.

Authors:  Guanying Luo; Yunzhao Hu; Zhiqiao Zhang; Peng Wang; Zhaowen Luo; Jinxin Lin; Canchang Cheng; You Yang
Journal:  Oncotarget       Date:  2017-07-25

7.  Clinicopathological and prognostic significance of Ki-67 immunohistochemical expression in gastric cancer: a systematic review and meta-analysis.

Authors:  Gang Liu; Disheng Xiong; Junjie Zeng; Borong Chen; Zhengjie Huang
Journal:  Onco Targets Ther       Date:  2017-09-01       Impact factor: 4.147

8.  Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients--a study of the OVCAD consortium.

Authors:  Anna Bachmayr-Heyda; Stefanie Aust; Georg Heinze; Stephan Polterauer; Christoph Grimm; Elena Ioana Braicu; Jalid Sehouli; Sandrina Lambrechts; Ignace Vergote; Sven Mahner; Dietmar Pils; Eva Schuster; Theresia Thalhammer; Reinhard Horvat; Carsten Denkert; Robert Zeillinger; Dan Cacsire Castillo-Tong
Journal:  BMC Cancer       Date:  2013-09-17       Impact factor: 4.430

9.  Ki67--An unsuitable marker of gastric cancer prognosis unmasks intratumoral heterogeneity.

Authors:  Christine Böger; Hans-Michael Behrens; Christoph Röcken
Journal:  J Surg Oncol       Date:  2015-12-28       Impact factor: 3.454

10.  Clinical implications of proliferation activity in T1 or T2 male gastric cancer patients.

Authors:  Young-Woo Kim; Bang Wool Eom; Myeong-Cherl Kook; Han-Seong Kim; Mi-Kyung Kim; Hai-Li Hwang; Vishal Chandra; Shiv Poojan; Yura Song; Jae-Soo Koh; Chang-Dae Bae; Jungsil Ro; Kyeong-Man Hong
Journal:  Exp Mol Med       Date:  2015-11-06       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.